EUVIMEDEUVIMED entdecken
Crossref

Polydopamine-Functionalized SiO2@MoS2 Nanocomposites Enable High Drug Loading and ROS-Associated In Vitro Anticancer Activity

Mahinour Elmowafy iD, Yuichi Negishi, Ahmed Abdelmoneim, Mahmoud Cyrus Soliman, Samir F El-Mashtoly, Amr Nassrallah

Biomedical Materials · 17.11.2026

DOI: 10.1088/1748-605x/aec346 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomedical Materials, online erschienen am 17.11.2026. Verfasst von Mahinour Elmowafy und 5 weiteren Autor:innen. Beteiligte Einrichtung: Alexandria University, Alexanderia, Alexandria, 11511, Egypt.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breast cancer is a major cause of cancer-related mortality worldwide, with a high incidence and significant healthcare burden. Despite the central role of chemotherapy, its effectiveness is hindered by systemic toxicity, drug resistance, and recurrence, underscoring the need for improved drug delivery strategies. This study investigates PDA-functionalised SiO₂@MoS₂ nanocomposites as carriers for DOX loading and pH-responsive release, together with their associated in vitro cellular responses. PMS was fabricated via a mussel-inspired coating strategy and thoroughly characterised to confirm successful core–shell construction and surface functionalization. Colloidal characterisation revealed formulation-dependent responses in serum-containing medium, with PMSD exhibiting a lower reported hydrodynamic diameter and PDI than MSD at 48 h. We evaluated the effects of the main loading parameters (pH, contact time, carrier dosage, and initial DOX concentration) and applied kinetic and isotherm models to describe the loading behaviour. Under the optimised conditions (drug-to-carrier ratio of 1:1, pH 6, 24 h), PMS achieved a DOX entrapment efficiency of 82% and a loading capacity of 820 mg g⁻¹. The in vitro release was pH-responsive, reaching approximately 82% at pH 5 compared with 54% at pH 7.4 within 24 h. Early-stage release was described using Higuchi and Korsmeyer–Peppas analyses. Their combined interpretation supported a diffusion-related contribution together with formulation and pH-dependent departures from a simple diffusion-only description. The DOX-loaded nanocomposites exhibited pronounced antiproliferative activity against breast cancer cells, while unloaded PMS maintained high viability in BJ-1 fibroblasts and MCF-10A breast epithelial cells across the tested concentration range following 24 h of exposure. Increased MDA levels and NAC-mediated attenuation of oxidation-sensitive fluorescence, accompanied by partial recovery of viability, supported an oxidative-stress contribution to PMSD-associated cytotoxicity. These findings demonstrate that PMS hybrid nanocomposites provide an efficient drug delivery platform for breast cancer treatment by integrating controlled release with cytotoxicity associated with increased intracellular oxidative activity.

Schlagwörter

Stichwörter der Autor:innen

BiomaterialsCancer TreatmentDrug DeliveryNanocarriers

Autor:innen und Institutionen

  • Alexandria University, Alexanderia, Alexandria, 11511, Egypt.
  • Institute of Multidisciplinary Research for Advanced Materials, Tohoku University, Sendai, Sendai, 980-8577, Japan.
  • Materials Science and Engineering , Egypt-Japan University of Science and Technology, New Borg EL-Arab City, Alexandria, 21934, Egypt.
  • Pharmacy Department, Egypt-Japan University of Science and Technology, Hod Sakrah WA Abu Hamad,, Borg El Arab , Alexandria, 21933, Egypt.
  • Leibniz Institute of Photonic Technology, jena, Jena, Thuringia, 07745, Germany.
  • Biotechnology Program, Egypt-Japan University of Science and Technology (, new borg elarab city, Alexandria, 21934, Egypt.

ORCID-Profile: Mahinour Elmowafy

Zitieren

APA

Elmowafy, M., Negishi, Y., Abdelmoneim, A., Soliman, M. C., El-Mashtoly, S. F., & Nassrallah, A. (2026). Polydopamine-Functionalized SiO2@MoS2 Nanocomposites Enable High Drug Loading and ROS-Associated In Vitro Anticancer Activity. Biomedical Materials. https://doi.org/10.1088/1748-605x/aec346

Vancouver

Elmowafy M, Negishi Y, Abdelmoneim A, Soliman MC, El-Mashtoly SF, Nassrallah A. Polydopamine-Functionalized SiO2@MoS2 Nanocomposites Enable High Drug Loading and ROS-Associated In Vitro Anticancer Activity. Biomedical Materials. 2026. doi:10.1088/1748-605x/aec346

BibTeX
@article{Elmowafy2026,
  author = {Elmowafy, Mahinour and Negishi, Yuichi and Abdelmoneim, Ahmed and Soliman, Mahmoud Cyrus and El-Mashtoly, Samir F and Nassrallah, Amr},
  title = {Polydopamine-Functionalized SiO2@MoS2 Nanocomposites Enable High Drug Loading and ROS-Associated In Vitro Anticancer Activity},
  journal = {Biomedical Materials},
  year = {2026},
  doi = {10.1088/1748-605x/aec346}
}
Kostenlos starten →